000 01863 a2200553 4500
005 20250514192234.0
264 0 _c20040818
008 200408s 0 0 eng d
022 _a0959-4973
024 7 _a10.1097/01.cad.0000132236.38297.a7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKatz, Daniela
245 0 0 _aNeoadjuvant imatinib for unresectable gastrointestinal stromal tumor.
_h[electronic resource]
260 _bAnti-cancer drugs
_cJul 2004
300 _a599-602 p.
_bdigital
500 _aPublication Type: Case Reports; Evaluation Study; Journal Article
650 0 4 _aBenzamides
650 0 4 _aBiopsy
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aDrug Administration Schedule
650 0 4 _aFollow-Up Studies
650 0 4 _aGastrectomy
650 0 4 _aGastrointestinal Neoplasms
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
650 0 4 _aIntestinal Polyps
_xdiagnosis
650 0 4 _aIsrael
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoadjuvant Therapy
_xmethods
650 0 4 _aNeoplasm Invasiveness
_xdiagnostic imaging
650 0 4 _aPiperazines
_xadministration & dosage
650 0 4 _aPostoperative Period
650 0 4 _aPyrimidines
_xadministration & dosage
650 0 4 _aRemission Induction
_xmethods
650 0 4 _aSplenectomy
650 0 4 _aStromal Cells
_xdrug effects
650 0 4 _aTomography, Spiral Computed
650 0 4 _aTreatment Outcome
700 1 _aSegal, Amiel
700 1 _aAlberton, Yossef
700 1 _aJurim, Oded
700 1 _aReissman, Petachia
700 1 _aCatane, Raphael
700 1 _aCherny, Nathan I
773 0 _tAnti-cancer drugs
_gvol. 15
_gno. 6
_gp. 599-602
856 4 0 _uhttps://doi.org/10.1097/01.cad.0000132236.38297.a7
_zAvailable from publisher's website
999 _c14911222
_d14911222